{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:39:06Z","timestamp":1792449546154,"version":"4.5.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373289"],"award-info":[{"award-number":["82373289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82388101"],"award-info":[{"award-number":["82388101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82522023"],"award-info":[{"award-number":["82522023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["WH510363004\/012"],"award-info":[{"award-number":["WH510363004\/012"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782145"],"award-info":[{"award-number":["2025M782145"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25SF1907104"],"award-info":[{"award-number":["25SF1907104"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM202411008"],"award-info":[{"award-number":["SZSM202411008"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.preteyeres.2026.101514","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:30:51Z","timestamp":1788305451000},"page":"101514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel insights into retinoblastoma: From oncogenic circuitry to precision diagnosis and eye-preserving therapies"],"prefix":"10.1016","volume":"115","author":[{"given":"Min","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-3969","authenticated-orcid":false,"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2026.101514_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-med-061312-123455","article-title":"Retinoblastoma: saving life with vision","volume":"65","author":"Abramson","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100015","article-title":"Retrospective evaluation of somatic alterations in cell-free DNA from blood in retinoblastoma","volume":"1","author":"Abramson","year":"2021","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.preteyeres.2026.101514_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156806","article-title":"Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (Tandem therapy)","volume":"11","author":"Abramson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101514_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaophthalmol.2023.6516","article-title":"Circulating tumor DNA posttreatment measurements and clinical correlates in retinoblastoma","volume":"142","author":"Abramson","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2026.101514_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40942-017-0093-8","article-title":"Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide","volume":"3","author":"Abramson","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.preteyeres.2026.101514_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ophtha.2019.12.005","article-title":"Next-generation sequencing of retinoblastoma identifies pathogenic alterations beyond RB1 inactivation that correlate with aggressive histopathologic features","volume":"127","author":"Afshar","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/24190","article-title":"Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A","volume":"396","author":"Ait-Si-Ali","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101514_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000331038","article-title":"Fine needle aspiration biopsy of retinal tumors","volume":"21","author":"Ali","year":"2012","journal-title":"Monogr. Clin. Cytol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1186\/s12885-019-6131-1","article-title":"CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing","volume":"19","author":"Andersch","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/cncr.11647","article-title":"Extraocular retinoblastoma: a 13-year experience","volume":"98","author":"Antoneli","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddag026","article-title":"Revisiting low penetrance retinoblastoma: an integrated clinical, genetic, and bioinformatic analysis","volume":"35","author":"Avnat","year":"2026","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1146\/annurev-pathol-012414-040259","article-title":"Genetics and epigenetics of human retinoblastoma","volume":"10","author":"Benavente","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib14","series-title":"Retinoblastoma Patient Clinical Database and Tissue Repository (Clinical Trial Registration No. NCT04959097)","author":"Berry","year":"2026"},{"key":"10.1016\/j.preteyeres.2026.101514_bib15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1158\/1541-7786.MCR-18-0369","article-title":"Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: the surrogate tumor biopsy for retinoblastoma","volume":"16","author":"Berry","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaophthalmol.2017.4097","article-title":"Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma","volume":"135","author":"Berry","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2026.101514_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of cell cycle transcription during G1 and S phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/neurintsurg-2016-012758","article-title":"Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study","volume":"9","author":"Boddu","year":"2017","journal-title":"J. Neurointerventional Surg."},{"key":"10.1016\/j.preteyeres.2026.101514_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2024.12.012","article-title":"The role of intravitreal chemotherapy as an adjunctive treatment for retinoblastoma: a systematic review and single-arm meta-analysis","volume":"273","author":"Bravo-Gonzalez","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/515499","article-title":"Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma","volume":"61","author":"Bremner","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.exer.2011.02.003","article-title":"Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo","volume":"92","author":"Burr","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12964-023-01223-z","article-title":"Retinoblastoma: present scenario and future challenges","volume":"21","author":"Byroju","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.preteyeres.2026.101514_bib23","article-title":"Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma","volume":"13","author":"C","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.preteyeres.2026.101514_bib24","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/pbc.25631","article-title":"A phase I study of the anti-idiotype vaccine racotumomab in neuroblastoma and other pediatric refractory malignancies","volume":"62","author":"Cacciavillano","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0165-4608(94)90459-6","article-title":"Phenotype variants, malignancy, and additional copies of 6p in retinoblastoma","volume":"76","author":"Cano","year":"1994","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00330-025-11853-1","article-title":"Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European retinoblastoma imaging collaboration and the European retinoblastoma group","volume":"36","author":"Cardoen","year":"2026","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib27","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1093\/nar\/gky366","article-title":"Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis","volume":"46","author":"Chai","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101030","article-title":"Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma","volume":"89","author":"Chai","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/bjo.2003.037044","article-title":"Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?","volume":"88","author":"Chantada","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib30","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.08-2737","article-title":"A phase I study of periocular topotecan in children with intraocular retinoblastoma","volume":"50","author":"Chantada","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejmg.2018.07.017","article-title":"Correlation between RB1 germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy","volume":"62","author":"Chaussade","year":"2019","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2013.01.008","article-title":"MRI in retinoblastoma with orbital cellulitis","volume":"120","author":"Chawla","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib34","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1200\/JCO.18.01808","article-title":"Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: a children's oncology group study","volume":"37","author":"Ch\u00e9vez-Barrios","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-9-reviews3012","article-title":"The retinoblastoma family: twins or distant cousins?","volume":"3","author":"Claudio","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28845","article-title":"Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions","volume":"68","author":"Cobbs","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib37","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMra1803083","article-title":"Retinoblastoma origins and destinations","volume":"390","author":"Cobrinik","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.6.18","article-title":"Dissecting the transcriptional and chromatin accessibility heterogeneity of proliferating cone precursors in human retinoblastoma tumors by single cell sequencing-opening pathways to new therapeutic strategies?","volume":"62","author":"Collin","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib39","first-page":"1434","article-title":"KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers","volume":"65","author":"Corson","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib40","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S1470-2045(14)70336-5","article-title":"Trilateral retinoblastoma: a systematic review and meta-analysis","volume":"15","author":"de Jong","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib41","series-title":"Clinical Ophthalmic Oncology: Retinoblastoma","first-page":"129","article-title":"Retinoblastoma: genetic counseling and testing","author":"DeBenedictis","year":"2024"},{"key":"10.1016\/j.preteyeres.2026.101514_bib42","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3567","article-title":"Molecular mechanisms underlying RB protein function","volume":"14","author":"Dick","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib43","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.preteyeres.2026.101514_bib44","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1038\/s41598-026-36833-3","article-title":"YTHDC1 modulates the malignant phenotype of retinoblastoma via SQSTM1-mediated autophagy","volume":"16","author":"Ding","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101514_bib45","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.83.19.7391","article-title":"Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas","volume":"83","author":"Dryja","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101514_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000132066","article-title":"Hereditary retinoblastoma and 13q\u2013 mosaicism","volume":"38","author":"Dudin","year":"2008","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib47","first-page":"3839","article-title":"Intensive multimodality therapy for extraocular retinoblastoma: a children's oncology group trial (ARET0321)","volume":"40","author":"Dunkel","year":"2022","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.preteyeres.2026.101514_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8466","article-title":"RB1 loss triggers dependence on ESRRG in retinoblastoma","volume":"8","author":"Field","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2026.101514_bib49","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \u201cAlive, with good vision and no comorbidity.\u201d","volume":"73","author":"Fl","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/cancers13010149","article-title":"Molecular changes in retinoblastoma beyond RB1: findings from next-generation sequencing","volume":"13","author":"Francis","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.preteyeres.2026.101514_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neo.2018.05.007","article-title":"Current treatment of bilateral retinoblastoma: the impact of intraarterial and intravitreous chemotherapy","volume":"20","author":"Francis","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.preteyeres.2026.101514_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/323643a0","article-title":"A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma","volume":"323","author":"Friend","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101514_bib53","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41467-025-57628-6","article-title":"In vivo prime editing rescues photoreceptor degeneration in nonsense mutant retinitis pigmentosa","volume":"16","author":"Fu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101514_bib54","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cancers16081565","article-title":"Genetic diagnosis of retinoblastoma using aqueous humour\u2014findings from an extended cohort","volume":"16","author":"Gerrish","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.preteyeres.2026.101514_bib55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bjophthalmol-2018-313005","article-title":"Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour","volume":"103","author":"Gerrish","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib56","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","article-title":"The global retinoblastoma outcome study: a prospective, cluster-based analysis of 4064 patients from 149 countries","volume":"10","author":"Global Retinoblastoma Study","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.preteyeres.2026.101514_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ncb1235","article-title":"Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin","volume":"7","author":"Gonzalo","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib58","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1038\/sj.onc.1208792","article-title":"Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma","volume":"24","author":"Grasemann","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.preteyeres.2026.101514_bib59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/0008-5472.CAN-06-1317","article-title":"Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma","volume":"67","author":"Gratias","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib60","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.21051","article-title":"Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation","volume":"116","author":"Gratias","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib61","article-title":"Cell-free DNA sequencing of intraocular fluid as liquid biopsy in the diagnosis of vitreoretinal lymphoma","volume":"12","author":"Gu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib62","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/cancers12102807","article-title":"Retinoblastoma tumor suppressor protein roles in epigenetic regulation","volume":"12","author":"Guzman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.preteyeres.2026.101514_bib63","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2002-04-1041","article-title":"Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors","volume":"100","author":"Haynes","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.preteyeres.2026.101514_bib64","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molcel.2015.01.036","article-title":"Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production","volume":"58","author":"He","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.preteyeres.2026.101514_bib65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.66.1.6","article-title":"A penetrable AAV2 capsid variant for efficient intravitreal gene delivery to the retina","volume":"66","author":"He","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature02820","article-title":"Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control","volume":"430","author":"Hernando","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101514_bib67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17460441.2013.772975","article-title":"Models and discovery strategies for new therapies of retinoblastoma","volume":"8","author":"Houston","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.preteyeres.2026.101514_bib68","article-title":"Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy","volume":"13","author":"Ht","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101514_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/gb4143","article-title":"Characterizing 5-methylcytosine in the mammalian epitranscriptome","volume":"14","author":"Hussain","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib70","article-title":"Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes","volume":"6","author":"Ie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101514_bib71","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222264","article-title":"MRI features for identifying MYCN-amplified RB1 wild-type retinoblastoma","volume":"307","author":"Jansen","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib72","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1148\/radiol.2018172000","article-title":"MR imaging features of retinoblastoma: association with gene expression profiles","volume":"288","author":"Jansen","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molcel.2004.09.029","article-title":"An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant","volume":"16","author":"Ji","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.preteyeres.2026.101514_bib74","first-page":"571","article-title":"Risk factors for cataract in retinoblastoma management","volume":"108","author":"Jia","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.658305","article-title":"Comparison of intra-arterial chemotherapy efficacy delivered through the ophthalmic artery or external carotid artery in a cohort of retinoblastoma patients","volume":"8","author":"Jia","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib76","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.cub.2012.02.030","article-title":"Checkpoint-Independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells","volume":"22","author":"Kabeche","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.62.14.8","article-title":"Intravitreal HDAC inhibitor belinostat effectively eradicates vitreous seeds without retinal toxicity in vivo in a rabbit retinoblastoma model","volume":"62","author":"Kaczmarek","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib78","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1158\/1078-0432.CCR-24-3271","article-title":"Update on retinoblastoma predisposition and surveillance recommendations for children","volume":"31","author":"Kamihara","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib79","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib80","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/labinvest.2015.104","article-title":"Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma","volume":"95","author":"Khan","year":"2015","journal-title":"Lab. Invest."},{"key":"10.1016\/j.preteyeres.2026.101514_bib81","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101514_bib82","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1002\/cam4.3144","article-title":"Cell\u2010free DNA profiling in retinoblastoma patients with advanced intraocular disease: an MSKCC experience","volume":"9","author":"Kothari","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/biomedicines13010108","article-title":"Oncolytic viruses and immunotherapy for the treatment of uveal melanoma and retinoblastoma: the current landscape and novel advances","volume":"13","author":"Kulbay","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.preteyeres.2026.101514_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104423","article-title":"Safety of intravitreal chemotherapy in the management of retinoblastoma: a systematic review of the literature","volume":"200","author":"Lavasidis","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib85","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ophtha.2003.08.036","article-title":"Chorioretinal scar growth after 810-nanometer laser treatment for retinoblastoma","volume":"111","author":"Lee","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib86","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/309458a0","article-title":"Expression and amplification of the N-myc gene in primary retinoblastoma","volume":"309","author":"Lee","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101514_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13287-026-04951-4","article-title":"Retinoblastoma: unveiling molecular pathogenesis and pioneering organoid-driven therapeutic innovations","volume":"17","author":"Li","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.preteyeres.2026.101514_bib88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.66.2.20","article-title":"Aurora A kinase inhibition is synthetic lethal with the activation of MYCN in retinoblastoma","volume":"66","author":"Liao","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.preteyeres.2026.101514_bib90","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.3390\/ijms25136910","article-title":"Histone deacetylases in retinoblastoma","volume":"25","author":"Lisek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib91","doi-asserted-by":"crossref","first-page":"33628","DOI":"10.1073\/pnas.2011780117","article-title":"Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin","volume":"117","author":"Liu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101514_bib92","article-title":"A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2026.101514_bib93","article-title":"Monitoring retinoblastoma by machine learning of aqueous humor metabolic fingerprinting","volume":"6","author":"Liu","year":"2022","journal-title":"Small Methods"},{"key":"10.1016\/j.preteyeres.2026.101514_bib94","series-title":"GeneReviews\u00ae","article-title":"Retinoblastoma","author":"Lohmann","year":"1993"},{"key":"10.1016\/j.preteyeres.2026.101514_bib95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajmg.c.30024","article-title":"Retinoblastoma: revisiting the model prototype of inherited cancer","volume":"129C","author":"Lohmann","year":"2004","journal-title":"Am. J. Med. Genet. Part C: Seminars in Medical Genetics"},{"key":"10.1016\/j.preteyeres.2026.101514_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101359","article-title":"Genetics and current research models of Mendelian tumor predisposition syndromes with ocular involvement","volume":"106","author":"Lozano","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib97","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/eye.2015.179","article-title":"Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy","volume":"30","author":"Lumbroso-Le Rouic","year":"2016","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2026.101514_bib98","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s11427-022-2288-4","article-title":"A novel MYCN-YTHDF1 cascade contributes to retinoblastoma tumor growth by eliciting m6A -dependent activation of multiple oncogenes","volume":"66","author":"Luo","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2021.09.026","article-title":"Contemporary update of retinoblastoma in China: Three-decade changes in epidemiology, clinical features, treatments, and outcomes","volume":"236","author":"Luo","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib100","series-title":"Asia-Pacific Journal of Ophthalmology","first-page":"13","article-title":"Recent progress in retinoblastoma: pathogenesis, presentation, diagnosis and management","author":"M","year":"2024"},{"key":"10.1016\/j.preteyeres.2026.101514_bib101","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/cancers18071175","article-title":"Reframing RB tumor suppressor dysfunction as a therapeutic vulnerability in cancer","volume":"18","author":"Malko","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.preteyeres.2026.101514_bib102","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1101\/gad.1917310","article-title":"Loss of pRB causes centromere dysfunction and chromosomal instability","volume":"24","author":"Manning","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.preteyeres.2026.101514_bib103","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40246-023-00529-w","article-title":"Genetics in ophthalmology: molecular blueprints of retinoblastoma","volume":"17","author":"Markovic","year":"2023","journal-title":"Hum. Genom."},{"key":"10.1016\/j.preteyeres.2026.101514_bib104","doi-asserted-by":"crossref","first-page":"438","DOI":"10.18632\/oncotarget.1686","article-title":"RB1 gene inactivation by chromothripsis in human retinoblastoma","volume":"5","author":"McEvoy","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.preteyeres.2026.101514_bib105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","article-title":"Classification and management of seeds in RetinoblastomaEllsworth lecture ghent August 24th 2013","volume":"35","author":"Munier","year":"2014","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib107","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e318203c101","article-title":"Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma","volume":"31","author":"Munier","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101514_bib108","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1086\/302138","article-title":"Evidence of somatic and germinal mosaicism in Pseudo\u2013low-penetrant hereditary retinoblastoma, by constitutional and single-sperm mutation analysis","volume":"63","author":"Munier","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib109","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/OTT.S370878","article-title":"Spotlight on targeted chemotherapy in retinoblastoma: safety, efficacy, and patient outcomes","volume":"15","author":"Naseripour","year":"2022","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.preteyeres.2026.101514_bib110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5981\/jjhnc.37.24","article-title":"Super-selective intra-arterial infusion chemotherapy with concurrent radiotherapy for cervical lymph node metastasis of oral cancers","volume":"37","author":"Nimura","year":"2011","journal-title":"Toukeibu Gan"},{"key":"10.1016\/j.preteyeres.2026.101514_bib111","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cancergencyto.2007.08.014","article-title":"Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses","volume":"179","author":"Paderova","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib112","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10555-025-10263-5","article-title":"Tumor heterogeneity in retinoblastoma: a literature review","volume":"44","author":"Pallavi","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.preteyeres.2026.101514_bib113","doi-asserted-by":"crossref","first-page":"8675","DOI":"10.3390\/ijms26178675","article-title":"Human retinal organoid modeling defines developmental window and therapeutic vulnerabilities in MYCN-amplified retinoblastoma","volume":"26","author":"Park","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9321","article-title":"Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01","volume":"11","author":"Pascual-Pasto","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib115","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1158\/1078-0432.CCR-24-0221","article-title":"Targeting GPC2 on intraocular and CNS metastatic retinoblastomas with local and systemic delivery of CAR T-cells","volume":"30","author":"Pascual-Pasto","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib116","article-title":"Comprehensive somatic copy number analysis using the aqueous humor liquid biopsy for retinoblastoma","volume":"62","author":"Polski","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib117","article-title":"Ocular delivery of the novel spleen tyrosine kinase inhibitor R406 for retinoblastoma","volume":"54","author":"Pritchard","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105210","article-title":"Efficacy of intra-arterial chemotherapy across intracranial tumors: a systematic review and meta-analysis","volume":"221","author":"Rahmanipour","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib119","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/neurintsurg-2019-014909","article-title":"Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis","volume":"11","author":"Ravindran","year":"2019","journal-title":"J. Neurointerventional Surg."},{"key":"10.1016\/j.preteyeres.2026.101514_bib120","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1177\/1120672121991390","article-title":"Treatment of small and medium retinoblastoma tumors with Iris diode laser","volume":"31","author":"Reynolds","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib121","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00134-015-4032-6","article-title":"Understanding PK\/PD","volume":"42","author":"Roberts","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib122","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0161-6420(03)00258-6","article-title":"Treatment of metastatic retinoblastoma","volume":"110","author":"Rodriguez-Galindo","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib123","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230852","article-title":"Association between MRI findings and causative variations in unilateral retinoblastoma","volume":"307","author":"Rollins","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100188","article-title":"High-level MYCN-amplified RB1-Proficient retinoblastoma tumors retain distinct molecular signatures","volume":"2","author":"Roohollahi","year":"2022","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.preteyeres.2026.101514_bib125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(13)70045-7","article-title":"Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies","volume":"14","author":"Rushlow","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib126","article-title":"NSUN2-mediated m5 C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression","volume":"13","author":"S","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.preteyeres.2026.101514_bib127","first-page":"880","article-title":"Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene","volume":"48","author":"Sakai","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccr.2011.04.017","article-title":"Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition","volume":"19","author":"Schvartzman","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.preteyeres.2026.101514_bib129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.survophthal.2025.08.008","article-title":"Intraocular seeds in retinoblastoma: a review of classification, management, and outcomes","volume":"71","author":"Sen","year":"2026","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib130","series-title":"Handbook of Animal Models and its Uses in Cancer Research","first-page":"1","article-title":"Tumor models of retinoblastoma: in vivo, Ex vivo, and in vitro models","author":"Sen","year":"2022"},{"key":"10.1016\/j.preteyeres.2026.101514_bib131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.64.15.31","article-title":"The use of rAAV2-RB1\u2013Mediated gene therapy in retinoblastoma","volume":"64","author":"Shi","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib132","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41433-022-01980-0","article-title":"Retinoblastoma: emerging concepts in genetics, global disease burden, chemotherapy outcomes, and psychological impact","volume":"37","author":"Shields","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2026.101514_bib133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/eye.2012.175","article-title":"Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy","volume":"27","author":"Shields","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2026.101514_bib134","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.jaapos.2017.07.037","article-title":"Intra-arterial chemotherapy versus intravenous chemotherapy for unilateral retinoblastoma who wins?","volume":"21","author":"Shields","year":"2017","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2026.101514_bib135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2026.101514_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000004283","article-title":"HIGH-DOSE intravitreal topotecan for recurrent retinoblastoma, subretinal seeds, and vitreous seeds","volume":"45","author":"Shields","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101514_bib137","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1442-9071.2010.02297.x","article-title":"Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey","volume":"38","author":"Shields","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib138","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41568-024-00769-5","article-title":"Chromothripsis in cancer","volume":"25","author":"Simovic-Lorenz","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib139","series-title":"Clinical Ophthalmic Oncology: Retinoblastoma","first-page":"209","article-title":"Retinoblastoma: enucleation","author":"Singh","year":"2024"},{"key":"10.1016\/j.preteyeres.2026.101514_bib140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjo-2022-322492","article-title":"Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity","volume":"108","author":"Stathopoulos","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib141","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ophtha.2021.01.014","article-title":"Imaging of schlemm's canal invasion in a retinoblastoma patient","volume":"128","author":"Stathopoulos","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib142","article-title":"GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma \u2013 assessing tumor and T cell interaction","volume":"14","author":"Sujjitjoon","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib143","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.21037\/tcr.2019.10.30","article-title":"HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin","volume":"8","author":"Sun","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101335","article-title":"RNA methylation homeostasis in ocular diseases: all eyes on me","volume":"105","author":"Tang","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/humu.20443","article-title":"Genotype\u2013phenotype correlations in hereditary familial retinoblastoma","volume":"28","author":"Taylor","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2026.101514_bib146","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1242\/bio.019976","article-title":"Establishment of a novel retinoblastoma (Rb) nude mouse model by intravitreal injection of human Rb Y79 cells \u2013 comparison of in vivo analysis versus histological follow up","volume":"5","author":"Tschulakow","year":"2016","journal-title":"Biol Open"},{"key":"10.1016\/j.preteyeres.2026.101514_bib147","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3928\/23258160-20151008-07","article-title":"Intravitreal lower-dose (20 \u03bcg) melphalan for persistent or recurrent retinoblastoma vitreous seeds","volume":"46","author":"Tuncer","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2026.101514_bib148","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.survophthal.2024.05.009","article-title":"Role of MYCN in retinoblastoma: a review of current literature","volume":"69","author":"Vempuluru","year":"2024","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib149","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1097\/IAE.0000000000004601","article-title":"HIGH-DOSE intravitreal topotecan (100 \u03bc G\/0.1 CC) as monotherapy for recurrent\/refractory intraocular retinoblastoma in seven eyes","volume":"45","author":"Vempuluru","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101514_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-23779-1","article-title":"Comprehensive analysis of single-cell and bulk RNA sequencing uncover tumor microenvironment diversity in invasive retinoblastoma","volume":"15","author":"Wan","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2026.101514_bib151","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","article-title":"GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision","volume":"1","author":"Wang","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.preteyeres.2026.101514_bib152","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bjo-2025-327728","article-title":"Intra-arterial chemotherapy for retinoblastoma: a performance analysis","volume":"109","author":"Weinberger","year":"2025","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib153","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s42003-022-04007-2","article-title":"Interruption of aberrant chromatin looping is required for regenerating RB1 function and suppressing tumorigenesis","volume":"5","author":"Wen","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib154","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2352-4642(23)00141-4","article-title":"Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial","volume":"7","author":"Wen","year":"2023","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.preteyeres.2026.101514_bib155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12809\/hkjo-v24n1-270","article-title":"Retinoblastoma in Hong Kong from 2008 to 2019: looking back and moving forward","volume":"24","author":"Wong","year":"2020","journal-title":"Hong Kong Journal of Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib156","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","article-title":"Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors","volume":"10","author":"Wong","year":"2022","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.preteyeres.2026.101514_bib157","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41698-021-00212-0","article-title":"Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy","volume":"5","author":"Wong","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib158","article-title":"Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling","volume":"137","author":"Xl","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2026.101514_bib159","doi-asserted-by":"crossref","first-page":"24902","DOI":"10.1074\/jbc.M115.680389","article-title":"Structural basis for the discriminative recognition of N6-Methyladenosine RNA by the human YT521-B homology domain family of proteins","volume":"290","author":"Xu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2026.101514_bib160","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/cancers13061282","article-title":"Establishing the clinical utility of ctDNA analysis for diagnosis, prognosis, and treatment monitoring of retinoblastoma: the aqueous humor liquid biopsy","volume":"13","author":"Xu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.preteyeres.2026.101514_bib161","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/1541-7786.MCR-19-1262","article-title":"Chromosome 6p amplification in aqueous humor cell-free DNA is a prognostic biomarker for retinoblastoma ocular survival","volume":"18","author":"Xu","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib162","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/13816810.2020.1799417","article-title":"Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes","volume":"41","author":"Xu","year":"2020","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2026.101514_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100820","article-title":"Diminished MYCN dosage endows cavitary transformation in retinoblastoma","volume":"5","author":"Xu","year":"2025","journal-title":"Ophthalmology Science"},{"key":"10.1016\/j.preteyeres.2026.101514_bib164","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature13813","article-title":"Rb suppresses human cone precursor-derived retinoblastoma tumors","volume":"514","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101514_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2026.07.015","article-title":"Eye-preserving therapies for early cT3c retinoblastoma","author":"Xu","year":"2026","journal-title":"Ophthalmology 0"},{"key":"10.1016\/j.preteyeres.2026.101514_bib166","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.62.15.11","article-title":"Xanthatin selectively targets retinoblastoma by inhibiting the PLK1-Mediated cell cycle","volume":"62","author":"Yang","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215870","article-title":"Novel insights into RB1 mutation","volume":"547","author":"Yao","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.preteyeres.2026.101514_bib168","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jama.2024.19981","article-title":"Three vs 6 cycles of chemotherapy for high-risk retinoblastoma: a randomized clinical trial","volume":"332","author":"Ye","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2026.101514_bib169","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1158\/1078-0432.CCR-08-3163","article-title":"Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells","volume":"15","author":"Yvon","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib170","article-title":"Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour","author":"Zhang","year":"2023","journal-title":"Cell. Oncol."},{"issue":"7381","key":"10.1016\/j.preteyeres.2026.101514_bib171","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature10733","article-title":"A novel retinoblastoma therapy from genomic and epigenetic analyses","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2026.101514_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156009","article-title":"Single-cell transcriptomic analyses provide insights into the tumor microenvironment heterogeneity and invasion phenotype in retinoblastoma","volume":"271","author":"Zhang","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.preteyeres.2026.101514_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108887","article-title":"SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo\/YAP signaling pathway","volume":"214","author":"Zhao","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101514_bib174","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2021.09.002","article-title":"Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China","volume":"129","author":"Zhou","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101514_bib175","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/bjophthalmol-2021-319118","article-title":"Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy","volume":"106","author":"Zhou","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101514_bib176","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.66.13.37","article-title":"Spatial proteomic analysis highlights molecular reprogramming in optic nerve invasive retinoblastoma","volume":"66","author":"Zhu","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101514_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1273","article-title":"NSUN2\u2010mediated m5 C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression","volume":"13","author":"Zuo","year":"2023","journal-title":"Clin. Transl. Med."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:40:36Z","timestamp":1792446036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946226000807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":177,"alternative-id":["S1350946226000807"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101514","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into retinoblastoma: From oncogenic circuitry to precision diagnosis and eye-preserving therapies","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101514"}}